Tweets
- Tweets
- Tweets & replies
- Media
@LSE_MTRG is blocked
Are you sure you want to view these Tweets? Viewing Tweets won't unblock @LSE_MTRG.
-
New
@EuWHOEurope report on Improving access to medicines through efficient public procurement http://goo.gl/u3Kpfd@a_ferrario@KanavosPG -
Essential Medicines for Universal Health Coverage: new Commission out today http://www.thelancet.com/commissions/essential-medicines …
#LancetEMC#essentialmeds@EMPCommissionpic.twitter.com/EGbU18oIL5
-
.
@VeroWirtz -#LancetEMC Commission proposes 24 indicators to measure progress on its recommendations#essentialmeds http://www.thelancet.com/journals/lancet/article/PIIS0140-6736(16)31599-9/fulltext …pic.twitter.com/2B9m1MZto6
-
WHO planning to convene stakeholders to develop fair medicine pricing model http://www.huffingtonpost.com/mariepaule-kieny/a-comprehensive-and-fair-_b_10695814.html …
-
Our Critique of the
@ASCO Value Assessment Framework for Cancer Treatments has just been published in@JCO_ASCO http://m.jco.ascopubs.org/content/early/2016/06/09/JCO.2015.64.9673 … -
LSE Health publish study on antibiotic innovation http://goo.gl/bsviOx
@mattjrenwick@MOSSIALOS@EdithSchippernlpic.twitter.com/ti2ShAOm0u
-
Talk and presentation given by Prof Light at LSE on 'The Good Pharma Model' are available online: http://goo.gl/AZdE9P
-
New study shows little competition in oral anti#cancer drugs means price increases over time after launch. Study: http://ow.ly/Tuw63001ypU
-
Drug Regulation and Pricing — Can Regulators Influence Affordability? — NEJMhttp://www.nejm.org/doi/full/10.1056/NEJMp1601294#.VzTrfFRIS5g.twitter …
-
How the MDGs gave up on measuring access to medicines: http://www.thelancet.com/journals/langlo/article/PIIS2214-109X(16)00066-8/abstract …
-
New report Towards better outcomes in multiple sclerosis by addressing policy change: The IMPrESS Study: http://goo.gl/kOV3BK
@KanavosPG -
New report on availability of medicines in Estonia http://goo.gl/UTXm55
@WHO_Europe@KanavosPG@a_ferrario -
.
@LSEHSC@OBShealth study outlines the urgent need for innovation in diagnostics for bacterial infection http://www.euro.who.int/en/about-us/partners/observatory/publications/studies/ensuring-innovation-in-diagnostics-for-bacterial-infection-implications-for-policy … -
An analysis of the review on antimicrobial resistance report & the infectious disease financing facility@MOSSIALOS http://www.globalizationandhealth.com/content/12/1/8
-
Sold out auditorium @
#LSEHealth public event on#Chinese Health Policy: Options for Reform@LSEHSC#healthpolicypic.twitter.com/2oWaAT7mmE
-
Our new paper led by
@ojwouters looks for evidence supporting private financing of healthcare - and finds little http://onlinelibrary.wiley.com/doi/10.1111/1758-5899.12211/abstract … -
Pharmaceutical policies in a crisis? Challenges and solutions identified at the PPRI Conference https://goo.gl/Ef081a
@editorjoppp -
LSE Summit presentations on rethinking regulation & value assessment of medical technologies are online:http://goo.gl/cmJyxo
#LSEmedtech -
#lsemedtech panel on future trends in HTA with@WHO_Europe@HAS_sante@EUnetHTApic.twitter.com/dPiCexAikH
Loading seems to be taking a while.
Twitter may be over capacity or experiencing a momentary hiccup. Try again or visit Twitter Status for more information.
LSE MTRG
The Lancet
Aris Angelis
LSEHealth&SocialCare
Access Our Medicine
Global Health Observ
(((Martin McKee)))
Alessandra Ferrario